Loading clinical trials...
Loading clinical trials...
The study is an unblinded randomized trial, designed to examine whether gastric- or jejunal feeding tubes are the most effect full to feed patients with alcoholic liver diseases and non-sufficient oral intake. The primary outcome will be differences in nutrition intake between the groups. Secondary outcomes will be: the amount of unplanned tube discontinuations; handgrip and patients' quality of life, nausea \& vomiting. The study will include 40 patients at Aarhus University Hospital, Denmark.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Aarhus University Hospital
Aarhus, Central Region, Denmark
Start Date
January 1, 2015
Primary Completion Date
April 1, 2018
Completion Date
April 1, 2018
Last Updated
April 20, 2018
40
ACTUAL participants
Gastric tube (Nutricia Flocare® Pur Tube Enlock)
DEVICE
Jejunal tube (Nutricia Flocare® Bengmark®)
DEVICE
Lead Sponsor
University of Aarhus
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03529019